Pharmacist Moms Group^™

Explore the latest FDA-approved treatments for hemophilia, including fitusiran and new anti-tissue factor inhibitors, enhancing patient care.

In this episode, the panel discusses key considerations for selecting and dosing VMAT2 inhibitors in tardive dyskinesia.

In this episode, the panel reviews the efficacy and safety data supporting deutetrabenazine and valbenazine for tardive dyskinesia.

Explore how pharmacists enhance access to care for multiple sclerosis patients, tackling barriers in diagnosis, treatment, and patient education.

GLP-1 receptor agonist effectiveness and tolerability can be significantly improved through targeted pharmacist counseling on alcohol reduction.

Pharmacists play a crucial role in educating multiple sclerosis patients about treatment options, side effects, and navigating insurance challenges.

Experts discuss the need for improved clinical trials in myelofibrosis, focusing on disease modification, patient outcomes, and potential new therapies.

Explore the evolving role of pharmacists in managing EGFR-mutated non-small cell lung cancer and the future of resistance-directed therapies.